Digestive Care, Inc. Confirms U.S. Manufacturing Capabilities
Digestive Care, Inc. (DCI) is the manufacturer of the only FDA approved enteric-coated Pancreatic Enzyme Replacement Therapy (PERT) that is manufactured in the United States. At a time when internationally outsourced pharmaceutical manufacturing has come under scrutiny, DCI confirms its flagship product Pertzye® (pancrelipase) is manufactured in Bethlehem, PA and we are committed to providing quality products using U.S. technology and ingenuity.
DCI is dedicated to developing unique pharmaceutical products to alleviate complications and symptoms of gastrointestinal disorders. PERTZYE® is the only PERT product formulated with enteric-coated microspheres containing pancreatic enzymes buffered with bicarbonate.